The Spore Drop

Eli Lilly's $3.8B Psychedelic Bet, a New Fungal Class, and the FDA's Biggest Psilocybin Move Yet

a new fungal class, a $3.8B deal, and a labor story nobody's talking about"

Psilocybin Breakthroughs: COMP360 Hits Phase 3 Endpoint, Natural Mushroom Framework Published, fPE7max Tool for Fungi

Synthetic psilocybin shows strong results in treatment-resistant depression, new review weighs entourage effects, and prime editing transforms fungal biotech

LSD Beats Depression, Mushrooms Wake a Dying Mind, and a Fungus Plays Favorites with Corn

one drug, one fungus, one really uncomfortable court case

Scientists Found a Fungus That Parasitizes the Zombie Fungus

A Hyperparasite, the Supreme Court, and the Slow Death of Just Say No

Global Mycorrhizal Map, Psilocybin Alzheimer’s Case, Ibogaine Legislation

fungi are storing 4 billion tons of carbon (and we’ve been farming over them)

The Fungi News You Missed This Week: Indoor Air, Drug Resistance, and Psilocybin's FDA Moment

the FDA blinked on psychedelics (+ your air quality is not what you think)

The Psychedelics Research Machine Didn’t Slow Down This Week

One Dose of Psilocybin Changed Brain Structure for a Month. Here’s What That Means.